Previous studies demonstrated that PCOS patients have impaired insulin signaling in skeletal muscle, including reduced insulin-stimulated phosphorylation of protein kinase B (Akt) and its 160 kDa substrate (AS160) [5], and increased phosphorylation of insulin receptor substrate 1 (IRS-1) [6]. The gene discussed is AKT1; the disease is polycystic ovary syndrome.